Vitamin D Status and Helicobacter Pylori Infection: Clinical Associations and Lipid Pathway Differences in an Exploratory Metabolomics Sub-Study

Why It Matters

The findings suggest that correcting vitamin D deficiency could become a complementary strategy in managing H. pylori infection and highlight lipid metabolism as a potential mechanistic link, informing both public‑health screening and therapeutic research.

Key Takeaways

• Vitamin D deficiency linked to 98% higher odds of H. pylori infection
• Insufficient and sufficient vitamin D reduce infection odds by 89% and 98%
• Female sex halves risk of H. pylori infection
• Metabolomics reveals disrupted sphingolipid metabolism in deficient individuals
• 50‑feature lipid panel discriminates vitamin D status with AUC ≈ 0.89

Pulse Analysis

Helicobacter pylori remains a pervasive cause of gastritis, ulcer disease and gastric cancer, especially in low‑ and middle‑income regions where infection rates can exceed 70 %. In the Middle East, prevalence is sustained by crowded living conditions and limited sanitation, while paradoxically, vitamin D deficiency is widespread despite abundant sunshine. The Lebanese cohort of 502 adults provides a rare opportunity to examine how a modifiable micronutrient intersects with bacterial colonisation. By measuring serum 25‑hydroxyvitamin D and confirming H. pylori status through breath tests or histology, the researchers captured a clear dose‑response relationship that persisted after adjusting for age, BMI, smoking and iron levels.

The multivariable logistic model revealed that participants with insufficient (20‑29 ng/mL) or sufficient (≥30 ng/mL) vitamin D had dramatically lower odds of infection—by 89 % and 98 % respectively—relative to deficient individuals (<20 ng/mL). Female sex also emerged as a protective factor, cutting risk roughly in half. These associations align with experimental data showing vitamin D‑receptor activation boosts antimicrobial peptides such as cathelicidin, enhancing mucosal immunity. Although iron deficiency was more common among infected subjects, it did not retain significance after adjustment, underscoring that vitamin D’s effect is not merely a surrogate for broader micronutrient status.

Beyond epidemiology, the untargeted metabolomics arm uncovered a distinct lipid signature in vitamin D‑deficient sera. Pathway enrichment pinpointed sphingolipid metabolism as the most perturbed, with glycerophospholipid and ether lipid routes also affected. Sphingolipids regulate membrane microdomains that H. pylori exploits for adhesion and immune evasion, suggesting that deficiency may create a lipid environment conducive to bacterial persistence. A 50‑feature lipid panel achieved an AUC of ~0.89 for classifying vitamin D status, indicating strong diagnostic potential. Together, these results advocate for integrated strategies that combine vitamin D screening, targeted supplementation, and conventional eradication therapy, while prompting longitudinal studies to untangle causality and explore lipid‑targeted interventions.